oral retatrutide drops 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide, an investigational triple hormone

This handy comparison table can help: Types of GLP-1 Medications Used for Weight Management While all GLP-1 drugs can indirectly support weight loss by acting on the GLP-1 hormones pathway and regulating metabolism, only a handful are approved by the FDA solely for this purpose

Losing weight in this way is immoral without the oversight of an IRB, and no IRB would allow such an obvious conflict of interest, where the subject gains significant health improvements in exchange for participating

Phebe Kuo, PA Physician Assistant Phebe joined MedOne in March 2025 and now brings seven years of clinical experience to MedOne Primary Care

Participants received once-weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks

Microdosing refers to lower-than-standard doses of semaglutide with slower increases

Who it's for